Display options
Share it on

Neural Regen Res. 2013 Nov 25;8(33):3148-58. doi: 10.3969/j.issn.1673-5374.2013.33.009.

Role of endoplasmic reticulum stress in the loss of retinal ganglion cells in diabetic retinopathy.

Neural regeneration research

Liping Yang, Lemeng Wu, Dongmei Wang, Ying Li, Hongliang Dou, Mark O M Tso, Zhizhong Ma

Affiliations

  1. Department of Ophthalmology, Peking University Third Hospital, Key Laboratory of Vision Loss and Restoration, Ministry of Education, Beijing 100191, China.
  2. Department of Ophthalmology, Peking University Third Hospital, Key Laboratory of Vision Loss and Restoration, Ministry of Education, Beijing 100191, China ; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

PMID: 25206636 PMCID: PMC4158709 DOI: 10.3969/j.issn.1673-5374.2013.33.009

Abstract

Endoplasmic reticulum stress is closely involved in the early stage of diabetic retinopathy. In the present study, a streptozotocin-induced diabetic animal model was given an intraperitoneal injection of tauroursodeoxycholic acid. Results from immunofluorescent co-localization experiments showed that both caspase-12 protein and c-Jun N-terminal kinase 1 phosphorylation levels significantly in-creased, which was associated with retinal ganglion cell death in diabetic retinas. The C/ERB mologous protein pathway directly contributed to glial reactivity, and was subsequently responsible for neuronal loss and vascular abnormalities in diabetic retinopathy. Our experimental findings dicate that endoplasmic reticulum stress plays an important role in diabetes-induced retinal neu-ronal loss and vascular abnormalities, and that inhibiting the activation of the endoplasmic reticulum stress pathway provides effective protection against diabetic retinopathy.

Keywords: C/ERB homologous protein; Müller cells; astrocytes; c-Jun N-terminal kinase; caspase-12 protein; diabetic retinopathy; endoplasmic reticulum stress; glial fibrillary acidic protein; grant-supported paper; injury of retinal ganglion cells; neural regeneration; neuroregeneration; peripheral nerve injury; retinal microcirculation

References

  1. Genes Dev. 2002 Jun 1;16(11):1345-55 - PubMed
  2. Prog Retin Eye Res. 2012 Jan;31(1):89-119 - PubMed
  3. Science. 2000 Jan 28;287(5453):664-6 - PubMed
  4. Gastroenterology. 1991 Jan;100(1):203-11 - PubMed
  5. Mol Cancer Ther. 2010 Oct;9(10):2641-51 - PubMed
  6. Prog Retin Eye Res. 2008 Nov;27(6):622-47 - PubMed
  7. Curr Pharm Des. 2007;13(26):2699-712 - PubMed
  8. J Mol Biol. 2002 May 17;318(5):1351-65 - PubMed
  9. Neuroscientist. 2010 Feb;16(1):79-106 - PubMed
  10. Brain Res. 2005 May 24;1044(2):227-40 - PubMed
  11. Prog Retin Eye Res. 2009 Jul;28(4):249-62 - PubMed
  12. J Neurosci Res. 2012 Oct;90(10):1960-9 - PubMed
  13. Exp Diabetes Res. 2012;2012:507986 - PubMed
  14. Science. 2006 Aug 25;313(5790):1137-40 - PubMed
  15. J Biol Chem. 2004 Apr 9;279(15):14844-52 - PubMed
  16. Neurochem Res. 2012 May;37(5):1091-101 - PubMed
  17. Exp Diabetes Res. 2012;2012:958169 - PubMed
  18. J Physiol. 2008 Sep 15;586(18):4401-8 - PubMed
  19. Mol Vis. 2011;17:1784-93 - PubMed
  20. Nature. 2000 Jan 6;403(6765):98-103 - PubMed
  21. Diabetologia. 2012 Sep;55(9):2417-20 - PubMed
  22. Diabetes Care. 1998 Jan;21(1):143-56 - PubMed
  23. Arch Ophthalmol. 1997 Sep;115(9):1161-6 - PubMed
  24. BMB Rep. 2008 May 31;41(5):345-52 - PubMed
  25. Cell Death Differ. 2006 Mar;13(3):363-73 - PubMed
  26. Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5191-8 - PubMed
  27. Am J Nephrol. 2008;28(6):1014-22 - PubMed
  28. Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3595-604 - PubMed
  29. Invest Ophthalmol Vis Sci. 2009 May;50(5):2319-27 - PubMed
  30. Neurobiol Dis. 2012 May;46(2):393-401 - PubMed

Publication Types